JP2001511347A5 - - Google Patents

Download PDF

Info

Publication number
JP2001511347A5
JP2001511347A5 JP2000504254A JP2000504254A JP2001511347A5 JP 2001511347 A5 JP2001511347 A5 JP 2001511347A5 JP 2000504254 A JP2000504254 A JP 2000504254A JP 2000504254 A JP2000504254 A JP 2000504254A JP 2001511347 A5 JP2001511347 A5 JP 2001511347A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
amino acids
polynucleotide
contiguous amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000504254A
Other languages
English (en)
Japanese (ja)
Other versions
JP4316133B2 (ja
JP2001511347A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US1998/015423 external-priority patent/WO1999005280A1/en
Publication of JP2001511347A publication Critical patent/JP2001511347A/ja
Publication of JP2001511347A5 publication Critical patent/JP2001511347A5/ja
Application granted granted Critical
Publication of JP4316133B2 publication Critical patent/JP4316133B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000504254A 1997-07-25 1998-07-24 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬 Expired - Lifetime JP4316133B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90090597A 1997-07-25 1997-07-25
US08/900,905 1997-07-25
PCT/US1998/015423 WO1999005280A1 (en) 1997-07-25 1998-07-24 Mammalian cytokine: interleukin-b30 and related reagents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005199240A Division JP2005323610A (ja) 1997-07-25 2005-07-07 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬

Publications (3)

Publication Number Publication Date
JP2001511347A JP2001511347A (ja) 2001-08-14
JP2001511347A5 true JP2001511347A5 (https=) 2006-01-05
JP4316133B2 JP4316133B2 (ja) 2009-08-19

Family

ID=25413278

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2000504254A Expired - Lifetime JP4316133B2 (ja) 1997-07-25 1998-07-24 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬
JP2005199240A Withdrawn JP2005323610A (ja) 1997-07-25 2005-07-07 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬
JP2009209861A Withdrawn JP2010011863A (ja) 1997-07-25 2009-09-10 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬
JP2012203186A Pending JP2013034480A (ja) 1997-07-25 2012-09-14 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬
JP2014184244A Pending JP2015037405A (ja) 1997-07-25 2014-09-10 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2005199240A Withdrawn JP2005323610A (ja) 1997-07-25 2005-07-07 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬
JP2009209861A Withdrawn JP2010011863A (ja) 1997-07-25 2009-09-10 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬
JP2012203186A Pending JP2013034480A (ja) 1997-07-25 2012-09-14 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬
JP2014184244A Pending JP2015037405A (ja) 1997-07-25 2014-09-10 哺乳動物サイトカイン：インターロイキン−ｂ３０および関連する試薬

Country Status (28)

Country Link
EP (3) EP2233574A1 (https=)
JP (5) JP4316133B2 (https=)
KR (1) KR100666835B1 (https=)
CN (2) CN101851286A (https=)
AR (2) AR017510A1 (https=)
AT (1) ATE443142T1 (https=)
AU (1) AU741046B2 (https=)
BR (1) BR9811039A (https=)
CA (1) CA2296272C (https=)
CO (1) CO4810232A1 (https=)
CZ (1) CZ300958B6 (https=)
DE (1) DE69841161D1 (https=)
DK (2) DK1002084T3 (https=)
ES (2) ES2610483T3 (https=)
HU (1) HU230629B1 (https=)
ID (1) ID28114A (https=)
IL (3) IL134068A0 (https=)
LT (1) LT2100959T (https=)
MY (1) MY157028A (https=)
NO (1) NO329329B1 (https=)
NZ (1) NZ502391A (https=)
PE (1) PE20000183A1 (https=)
PL (1) PL197150B1 (https=)
PT (2) PT2100959T (https=)
SK (1) SK287198B6 (https=)
TW (1) TWI237057B (https=)
WO (1) WO1999005280A1 (https=)
ZA (1) ZA986596B (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060284A (en) 1997-07-25 2000-05-09 Schering Corporation DNA encoding interleukin-B30
ATE329928T1 (de) * 1997-10-23 2006-07-15 Nippon Inst For Biolog Science Granulozyten-kolonie-stimulierender faktor aus der katze
WO1999040195A1 (en) * 1998-02-06 1999-08-12 Schering Corporation Mammalian receptor proteins; related reagents and methods
DE69942607D1 (de) 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein
AU2005202420B2 (en) * 1999-09-09 2008-08-07 Merck Sharp & Dohme Corp. Mammalian cytokines; related reagents and methods
AU780163B2 (en) * 1999-09-09 2005-03-03 Merck Sharp & Dohme Corp. Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
EP1905832A3 (en) 1999-09-09 2009-09-09 Schering Corporation Mammalian interleukin-12 P40 and interleukin B30, combinations thereof, antibodies, uses in pharmaceutical compositions
US7090847B1 (en) 1999-09-09 2006-08-15 Schering Corporation Mammalian cytokines; related reagents and methods
WO2004042009A2 (en) 2002-10-30 2004-05-21 Genentech, Inc. Inhibition of il-17 production
CN101052726A (zh) 2003-05-09 2007-10-10 森托科尔公司 IL－23p40特异性免疫球蛋白衍生蛋白、组合物、方法和用途
WO2005108425A1 (en) * 2004-05-10 2005-11-17 Cytos Biotechnology Ag Il-23 p19 antigen array and uses thereof
AR051444A1 (es) 2004-09-24 2007-01-17 Centocor Inc Proteinas derivadas de inmunoglobulina especifica de il-23p40, composiciones, epitopos, metodos y usos
SI2452694T1 (sl) 2005-06-30 2019-05-31 Janssen Biotech, Inc. Protitelesa proti-IL-23, sestavki in postopki uporabe
HUE034269T2 (en) 2005-12-29 2018-02-28 Janssen Biotech Inc Human anti-IL-23 antibodies, preparations, methods and applications
US7790862B2 (en) 2006-06-13 2010-09-07 Zymogenetics, Inc. IL-17 and IL-23 antagonists and methods of using the same
US7910703B2 (en) 2006-03-10 2011-03-22 Zymogenetics, Inc. Antagonists to IL-17A, IL-17F, and IL-23P19 and methods of use
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
EP2650311A3 (en) 2007-11-27 2014-06-04 Ablynx N.V. Amino acid sequences directed against heterodimeric cytokines and/or their receptors and polypeptides comprising the same
RU2474588C2 (ru) 2008-05-05 2013-02-10 Новиммун Са Перекрестно-реактивные антитела анти-il-17a/il-17f и способы их применения
CN102458437B (zh) 2009-05-05 2015-06-10 诺维莫尼公司 抗il-17f抗体及其使用方法
JO3244B1 (ar) 2009-10-26 2018-03-08 Amgen Inc بروتينات ربط مستضادات il – 23 البشرية
MX2019000046A (es) 2010-11-04 2023-10-05 Boehringer Ingelheim Int Anticuerpos anti-il-23.
PL3326649T3 (pl) 2012-05-03 2022-04-25 Boehringer Ingelheim International Gmbh Przeciwciała anty-il-23p19
SG11201507483PA (en) 2013-03-15 2015-10-29 Amgen Inc Methods for treating crohn's disease using an anti-il23 antibody
SG11201507482UA (en) 2013-03-15 2015-10-29 Amgen Inc Methods for treating psoriasis using an anti-il-23 antibody
EP3708679A1 (en) 2014-07-24 2020-09-16 Boehringer Ingelheim International GmbH Biomarkers useful in the treatment of il-23a related diseases
EA202193002A2 (ru) 2014-09-03 2022-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Соединение, нацеленное на ил-23a и фно-альфа, и его применение
AU2016215535B2 (en) 2015-02-04 2021-09-16 Boehringer Ingelheim International Gmbh Methods of treating inflammatory diseases
CN108290058B (zh) 2015-09-17 2023-05-16 美国安进公司 使用il23途径生物标志物预测il23拮抗剂的临床应答
US11220541B2 (en) 2015-12-22 2022-01-11 Amgen Inc. CCL20 as a predictor of clinical response to IL23-antagonists
CN112689643A (zh) 2018-07-13 2021-04-20 阿斯特捷利康合作创业有限责任公司 用布雷库单抗治疗溃疡性结肠炎
IL283192B2 (en) 2018-11-20 2025-10-01 Janssen Biotech Inc A safe and effective method for treating psoriasis with a specific anti-IL-23 antibody
JP7805788B2 (ja) 2019-05-23 2026-01-26 ヤンセン バイオテツク，インコーポレーテツド Ｉｌ－２３及びｔｎｆアルファに対する抗体の併用療法による炎症性腸疾患の治療方法
TW202535466A (zh) 2019-09-09 2025-09-16 德商百靈佳殷格翰國際股份有限公司 抗-il-23p19抗體調配物
JP7758672B2 (ja) 2019-12-20 2025-10-22 ノヴァロック バイオセラピューティクス， リミテッド 抗インターロイキン－２３ ｐ１９抗体およびそれの使用方法
IL298389A (en) 2020-05-21 2023-01-01 Janssen Biotech Inc Method of treating inflammatory bowel disease with a combination therapy of antibodies to il-23 and tnf alpha

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2046920B1 (https=) 1969-06-19 1974-05-03 Citizen Watch Co Ltd
US3940475A (en) 1970-06-11 1976-02-24 Biological Developments, Inc. Radioimmune method of assaying quantitatively for a hapten
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3382317D1 (de) 1982-03-15 1991-07-25 Schering Corp Hybride dns, damit hergestellte bindungszusammensetzung und verfahren dafuer.
US4659678A (en) 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4859609A (en) 1986-04-30 1989-08-22 Genentech, Inc. Novel receptors for efficient determination of ligands and their antagonists or agonists
US5891680A (en) * 1995-02-08 1999-04-06 Whitehead Institute For Biomedical Research Bioactive fusion proteins comprising the p35 and p40 subunits of IL-12
DE69942607D1 (de) * 1998-04-14 2010-09-02 Chugai Pharmaceutical Co Ltd Neues cytokinartiges protein

Similar Documents

Publication Publication Date Title
JP2001511347A5 (https=)
CA2296272A1 (en) Mammalian cytokine: interleukin-b30 and related reagents
JP2002521055A5 (https=)
JP2002518010A5 (https=)
JP2003534013A5 (https=)
FR14C0061I2 (fr) Sequences de circovirus associe a la maladie de l'amaigrissement du porcelet (map)
JP2002502589A5 (https=)
JP2003501038A5 (https=)
CA2215394A1 (en) Il-17 receptor
CA2343979A1 (en) Human interleukin-b50, therapeutic uses
JP2003511007A5 (https=)
JP2003527109A5 (https=)
AU2004287645A1 (en) Variants of human glycoprotein hormone alpha chain: compositions and uses thereof
JP2002512005A5 (https=)
JP2003531634A5 (https=)
JPH1066585A5 (https=)
JP2003510078A5 (https=)
EP0973887B1 (en) Porcine leptin protein, nucleic acid sequences coding therefor and uses thereof
JP2005528894A5 (https=)
US20210382070A1 (en) Diagnostic biomarkers for shrimp allergy
JP2008509659A5 (https=)
US6297027B1 (en) Bovine leptin protein, nucleic acid sequences coding therefor and uses thereof
JPH04218388A (ja) ソマトトロピン結合蛋白質を特異的に認識する抗体
JP2006519582A5 (https=)
EP1566386A1 (en) A baldness related gene and the polypeptide encoded thereby, and uses thereof